Diab Core Update Feb 2021
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - January 27, 2021 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
TWiV 697: The sky is NOT falling
TWiV reviews the latest data on the UK variant of SARS-CoV-2, including some properties of the variant and why it is being closely studied, development of liver cancer in a participant in a adenovirus-associated virus gene therapy trial, and answers to listener questions. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode BSL-3 Assistant Manager position 3:39 NERVTAG meeting minutes (pdf) NERVTAG Preliminary genomic characterization of UK variant (virological.org) PHE investigation of UK var...
Source: This Week in Virology - MP3 Edition - December 24, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Nebulized Magnesium for Child Asthma, Hemochromatosis and Liver Cancer, USPSTF Guideline on Lifestyle Counseling for CVD Prevention, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 24, 2020 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 24, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Diabetes Core Update – October 2020
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - October 11, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Diabetes Core Update – February 2019
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - January 25, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
Listen to an audio podcast of the August 28, 2019 FDA Drug Safety Communication: FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi with advanced liver disease. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 21, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
14 November 2019: A rapid, multi-material 3D printer, and a bacterium ’s role in alcoholic hepatitis
This week, a new 3D printer allows quick shifting between many materials, and understanding the link between gut microbes and liver disease.00:46 A new dimension for 3D printersA new nozzle lets a 3D printer switch between materials at a rapid rate, opening the door to a range of applications. Research Article: Skylar-Scott et al.; News and Views: How to print multi-material devices in one go08:07 Research HighlightsThe slippery secrets of ice, and cells wrapping up their nuclei. Research Highlight: Viscous water holds the secret to an ice skater’s smooth glide; Research Highlight: ...
Source: Nature Podcast - November 13, 2019 Category: Science Authors: Springer Nature Limited Source Type: podcasts
14 November 2019: A rapid, multi-material 3D printer, and a bacterium ’s role in alcoholic hepatitis
This week, a new 3D printer allows quick shifting between many materials, and understanding the link between gut microbes and liver disease.00:46 A new dimension for 3D printersA new nozzle lets a 3D printer switch between materials at a rapid rate, opening the door to a range of applications. Research Article: Skylar-Scott et al.; News and Views: How to print multi-material devices in one go08:07 Research HighlightsThe slippery secrets of ice, and cells wrapping up their nuclei. Research Highlight: Viscous water holds the secret to an ice skater’s smooth glide; Research Highlight: ...
Source: Nature Podcast - November 13, 2019 Category: Science Authors: Springer Nature Limited Source Type: podcasts
FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
Listen to an audio podcast of the August 28, 2019 FDA Drug Safety Communication: FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi with advanced liver disease. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - September 11, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA adds Boxed Warning to highlight correct dosing of Ocaliva (obeticholic acid) for patients with a rare chronic liver disease
Listen to an audio podcast of the February 1, 2018 FDA Drug Safety Communication warning that the liver disease medicine Ocaliva (obeticholic acid) has been incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, increasing the risk of serious liver injury. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts
JAMA Internal Medicine : Association of Weight Loss Interventions With Changes in NAFLD Biomarkers
Interview with Dimitrios A. Koutoukidis, PhD, author of Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 1, 2019 Category: General Medicine Source Type: podcasts
COSMIC-312 Trial in HCC
Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, Liver Program Disease Team Lead, City of Hope explains the design of the COSMIC-312 study in hepato...
Author: obr
Added: 06/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 28, 2019 Category: Cancer & Oncology Source Type: podcasts
